APA (7th ed.) Citation

S, M., DW, V. P., JG, S., J, D., SE, M., RJ, B., . . . S, M. (2026). Nw-Hydroxy L-Arginine (NOHA): A Promising Biomarker of Response to Neoadjuvant Therapy in the Management of Triple Negative Breast Cancer. Cancer reports (Hoboken, N.J.), 9(7), e70609. https://doi.org/10.1002/cnr2.70609

Chicago Style (17th ed.) Citation

S, Mohan, Van Pelt DW, Saunders JG, DiPalazzo J, Monahan SE, Buchsbaum RJ, Frankenfeld CL, Bertaux BY, and Miesfeldt S. "Nw-Hydroxy L-Arginine (NOHA): A Promising Biomarker of Response to Neoadjuvant Therapy in the Management of Triple Negative Breast Cancer." Cancer Reports (Hoboken, N.J.) 9, no. 7 (2026): e70609. https://doi.org/10.1002/cnr2.70609.

MLA (9th ed.) Citation

S, Mohan, et al. "Nw-Hydroxy L-Arginine (NOHA): A Promising Biomarker of Response to Neoadjuvant Therapy in the Management of Triple Negative Breast Cancer." Cancer Reports (Hoboken, N.J.), vol. 9, no. 7, 2026, p. e70609, https://doi.org/10.1002/cnr2.70609.